Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer
PLoS ONE - United States
doi 10.1371/journal.pone.0182166
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 28, 2017
Authors
Publisher
Public Library of Science (PLoS)